Safety of budesonide inhalation suspension in infants aged six to twelve months with mild to moderate persistent asthma or recurrent wheeze

Journal of Pediatrics

Volumn 146, Issue 1, 2005, Pages 91-95

  Berger, William E ^a   Qaqundah, Paul Y ^a   Blake, Kathryn ^a   Rodriguez Santana, Jose ^a   Irani, Anne Marie ^a   Xu, John ^a   Goldman, Mitchell ^a  

^a Allerg Asthma Assoc S California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; ORCIPRENALINE; PLACEBO; PREDNISOLONE; PREDNISONE; TETRACOSACTIDE;

ADRENAL FUNCTION; ARTICLE; ASTHMA; CLINICAL TRIAL; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; DISEASE EXACERBATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; FEVER; HUMAN; HYDROCORTISONE BLOOD LEVEL; INFANT; LABORATORY TEST; MALE; MULTICENTER STUDY; OTITIS MEDIA; PHARYNGITIS; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RECURRENT DISEASE; RESPIRATORY TRACT INFECTION; RHINITIS; SINUSITIS; TOOTH DISEASE; TOOTH ERUPTION; TOOTH PAIN; VIRUS INFECTION; VOMITING; WHEEZING;

ADMINISTRATION, INHALATION; ADRENAL GLANDS; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYDROCORTISONE; INFANT; MALE; NEBULIZERS AND VAPORIZERS; RESPIRATORY SOUNDS;

EID: 11844255396     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2004.08.060     Document Type: Article

References (13)

1. National Asthma Education and Prevention Program Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma Update on Selected Topics: 2002 J Allergy Clin Immunol 110 Suppl 5 2002 S141 S219
2. J.G. Leflein, S.J. Szefler, K.R. Murphy, S. Fitzpatrick, M. Cruz-Rivera, and C.J. Miller Nebulized budesonide inhalation suspension compared with cromolyn sodium nebulizer solution for asthma in young children: results of a randomized outcomes trial Pediatrics 109 2002 866 872
3. G. Shapiro, L. Mendelson, M.J. Kraemer, M. Cruz-Rivera, K. Walton-Bowen, and J.A. Smith Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid-dependent, persistent asthma J Allergy Clin Immunol 102 1998 789 796
4. J.P. Kemp, D.P. Skoner, S.J. Szefler, K. Walton-Bowen, M. Cruz-Rivera, and J.A. Smith Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children Ann Allergy Asthma Immunol 83 1999 231 239
5. J.W. Baker, M. Mellon, J. Wald, M. Welch, M. Cruz-Rivera, and K. Walton-Bowen A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants Pediatrics 103 1999 414 421
6. J.G. Leflein, S.M. Gawchik, S.P. Galant, E. Lyzell, M. Young, and M. Cruz-Rivera Safety of budesonide inhalation suspension (Pulmicort Respules) after up to 52 weeks of treatment in infants and young children with persistent asthma Allergy Asthma Proc 22 2001 359 366
7. A.-M. Irani, M. Cruz-Rivera, S. Fitzpatrick, J. Hoag, and J.A. Smith Effects of budesonide inhalation suspension on hypothalamic-pituitary-adrenal- axis function in infants and young children with persistent asthma Ann Allergy Asthma Immunol 88 2002 306 312
8. S.K. Grinspoon, and B.M.K. Biller Clinical review 62: laboratory assessment of adrenal insufficiency J Clin Endocrinol Metab 79 1994 923 931
9. G.P. Chrousos, and A.G. Harris Hypothalamic-pituitary-adrenal axis suppression and inhaled corticosteroid therapy, I: general principles Neuroimmunomodulation 5 1998 277 287
10. S.J. Szefler, E. Lyzell, S. Fitzpatrick, and M. Cruz-Rivera Safety profile of budesonide inhalation suspension in the pediatric population: worldwide experience Ann Allergy Asthma Immunol 93 2004 83 90
11. The Childhood Asthma Management Program Research Group Long-term effects of budesonide or nedocromil in children with asthma N Engl J Med 343 2000 1054 1063
12. L. Agertoft, and S. Pedersen Effect of long-term treatment with inhaled budesonide on adult height in children with asthma N Engl J Med 343 2000 1064 1069
13. J.P. Kemp Study designs and challenges in clinical studies conducted in infants and children with asthma J Allergy Clin Immunol 104 1999 S184 S190